Pro Palmitoylethanolamide (PEA)

Supports the endocannabinoid system
- Scientifically proven to help reduce chronic pain and inflammation
- A naturally occurring long-chain fatty acid amide typically produced in response to various triggers, including inflammation
- Provides a multi-pronged approach to activate and maintain the endocannabinoid system
- Studied for 80 years and over 300 medical studies
Palmitoylethanolamide (PEA) is a long-chain fatty acid produced naturally by the body, but is also found in foods such as egg yolk, soybean and sunflower oils. This molecule, studied for its unique and broad range of health benefits for eighty years, is now receiving increased attention due to its crucial role in the endocannabinoid system (ECS). The ECS is a communication network that maintains cellular homeostasis, particularly when tissues are damaged, inflamed, or injured. PEA is an endocannabinoid produced locally by cells, following any injury, physical stress or pain. By inhibiting the activation of mast cells that cause further inflammation (such as the release of histamine), PEA acts as a powerful anti-inflammatory agent. This unique molecule has other direct and indirect mechanisms of action; it enhances the action of other endocannabinoids thanks to its “entourage effect” and its action on many new cellular receptors, including PPAR. The PEA molecule has been clinically shown to have the ability to relieve pain in knee osteoarthritis as well as reduce symptoms of low back pain, and is well tolerated for athletes, children and the elderly.
AOR Advantage
AOR is leading the way in transforming the impressive and evolving research into the positive effects of EEP in the human endocannabinoid system, bringing your patients a safe and therapeutic formulation to combat chronic pain and systemic inflammation. The P.E.A. from AOR is produced in Italy and extracted from environmentally sustainable Malaysian palm oil that is responsibly purified and processed for optimal bioavailability.